BioSpace News Archive

Patient-centric healthcare apps are applications that run on smartphones, and provide updates regarding medicine dosage timings, number of calories consumed, dehydration levels in body, and other body parameters of the patient or user.

Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced the appointment of Tim Kelly, PhD, as President of Manufacturing. He will oversee all manufacturing functions at AskBio and its Viralgen affiliate for the production of clinical- and commercial-scale AAV vectors.

New efforts and protocol added to ensure company provides the best experience to every club member

VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing.

PatientPoint platform to deliver AAD education at key touchpoints along the patient care journey

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for the clinical development of PhageBank™, a personalized bacteriophage therapeutic for the treatment of MDR and complicated bacterial infections.

As the Centers for Disease Control and Prevention (CDC) and California Department of Public Health (CDPH) announced this week new protocols and requirements for minimizing the continuing spread of the Novel Coronavirus (COVID-19), Brown & Toland has developed communications to support member awareness and physician preparedness.

The Biological Products Industry Alliance (BPIA) named Valent BioSciences (VBC) its “Member of the Year” at the organization’s 2020 Annual Meeting and Symposium, held March 2-4 in Portland, Oregon

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on the inventory related challenges affecting pharmaceutical companies.

CoNextions Inc. (www.conextionsmed.com) announced today that it received a 510(k) clearance (K200028) from the U.S. Food and Drug Administration (FDA) for CoronetTM System, a tenodesis product intended for the fixation of tissue to bone and tissue to tissue.